Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teknika wins patent dispute over Nucleic Acid Sequence Based Amplification (NASBA):

This article was originally published in Clinica

Executive Summary

Netherlands-based diagnostics manufacturer Organon Teknika has won a patent dispute concerning its NASBA HIV tests with Roche. The Swiss pharmaceutical company claimed in September that Teknika's test infringed Roche's European PCR patent. However, on December 14th the president of the district court at The Hague rejected all of Roche's claims and granted Teknika's counter-claim that Roche should publicly announce the contents of the judgement. Teknika says it has begun legal action in the UK, France and Germany to obtain declarations of non-infringement and is preparing similar action in other countries.

Topics

UsernamePublicRestriction

Register

MT094562

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel